Autobio Diagnostics

Autobio Diagnostics Co., Ltd. was founded in 1998. It is a high-tech enterprise focusing on the R&D, manufacturing, integration, and service of IVD reagents and instruments. Its products cover immunoassay, microbiology, biochemistry, molecular, coagulation, etc. The company has also made arrangements in precision detection fields like sequencing and mass spectrometry, and can provide comprehensive product solutions and overall services for medical laboratories. The company was listed on the stock market on September 1st, 2016, and is the first IVD R&D and manufacturing enterprise to be listed on the main board of the Shanghai Stock Exchange in China.

Autobio has strong innovation capabilities, undertakes a number of national scientific and technological projects, participates in the formulation of 101 industry standards, and its products have entered more than 10,000 medical institutions and are exported overseas. Its IVD industrial park is a provincial key project, covering 167,333 m2 of construction land with a building area of over 720,000 m2. It will become one of the largest IVD industrial parks in China. Adhering to its tenet, Autobio drives high-quality development through innovation and aims to build an integrated IVD enterprise.